Tetsu Watanabe
Director/Board Member bei TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Profil
Tetsu Watanabe currently works at Taisho Pharmaceutical Co., Ltd., as Director & Managing Executive Officer from 2016 and Taisho Pharmaceutical Holdings Co., Ltd., as Director & Head-Corporate Communications from 2015.
Aktive Positionen von Tetsu Watanabe
Unternehmen | Position | Beginn |
---|---|---|
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Board Member | 01.06.2015 |
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Director/Board Member | 01.06.2015 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Health Technology |